End Hep C SD

End Hep C SD EndHepCSD is a public-private partnership to eliminate hepatitis C by 2030. To get involved, visit www.endhepcsd.org for meeting information.

End Hep C SD is the public campaign name for the Eliminate Hepatitis C San Diego County Initiative. We work to advance the health and dignity of people living with and impacted by hepatitis C, and intersecting epidemics, by advocating for the enhancement of governmental, private, and public health care systems through capacity building and a commitment to social justice. This initiative is current

ly funded by the County of San Diego, Health and Human Services Agency. Additional funding is provided by unrestricted educational grants/support to the Liver Coalition of San Diego — the convening agency —by AbbVie, Inc. and Gilead Sciences.

04/02/2026

No Health Without Liver Health

Liver cancer is one of the fastest‑growing cancers in the nation — but most cases are preventable. Our work at the Liver Coalition of San Diego intersects every day with the mission of SDCountyHHSA’s Public Health Services, and together we focus on four actions that make a real difference:

- Maintain a healthy weight
- Avoid alcohol
- Get vaccinated for hepatitis B
- Get tested — and treated if positive — for hepatitis C

As we join the American Public Health Association to recognize this month, we are proud to be one of the many healthcare organizations partnering with the County to advance prevention, early detection, and access to care so every community has the chance to be healthier. Together, we work with decision‑makers to put health at the center of all policymaking, knowing that smart local policies save lives.

Appreciation to Dr. Sayone Thihalolipavan, Chief Public Health Officer for San Diego County, for his leadership and commitment to building a healthier region.

02/24/2026

Black Americans continue to face some of the highest burdens of liver disease — from faster progression of MASLD/MASH to higher rates of liver cancer and lower access to specialty care. These disparities are real, persistent, and preventable.

That’s why the latest announcement from the Centers for Medicare & Medicaid Services (CMS) matters for our community.

CMS has released the third cycle of drugs selected for Medicare price negotiation under the Inflation Reduction Act. Lenvima — a treatment for liver cancer — is on the list.

Last year, Xifaxan, used to reduce the risk of hepatic encephalopathy in people with cirrhosis, was selected. Its negotiated Medicare price of $1,000 will take effect in 2027.

The negotiated prices for Lenvima and the 14 other drugs in this new cycle will be announced at the end of this year and take effect in 2028.

As we honor Black History Month, we must recognize that policy decisions about drug pricing directly affect communities already carrying disproportionate burdens of liver disease.

Health equity requires both affordability and continued innovation, especially for conditions where Black patients experience higher mortality and fewer treatment options.

This is a moment for thoughtful dialogue, patient‑centered policy, and a commitment to ensuring that breakthroughs in liver health reach every community.

Learn more from our advocacy partner AASLD: https://www.aasld.org/policy-communications?ct=YTo2OntzOjY6InNvdXJjZSI7YToyOntpOjA7czo1OiJlbWFpbCI7aToxO2k6MTExNDt9czo1OiJlbWFpbCI7aToxMTE0O3M6NDoic3RhdCI7czoyMjoiNjk4MjYxZTk3M2Y3ZDMyNjc1NTAxNyI7czo5OiJzZW50X3RpbWUiO2k6MTc3MDE1MjQyNTtzOjQ6ImxlYWQiO3M6NjoiMTU5OTgzIjtzOjc6ImNoYW5uZWwiO2E6MTp7czo1OiJlbWFpbCI7aToxMTE0O319

01/20/2026

Liver cancer is rising quickly, but 60% of cases are preventable through early detection. Thank you, Congressman David G. Valadao, for your support of the . Now is the time to pass it and strengthen early detection for Californians.

01/20/2026

Street medicine teams from Family Health Centers bring clinic-level care to San Diego’s homeless encampments, treating addiction and chronic disease.

01/02/2026

⏰ Hepatitis B Cases in California Rank the Highest ⏰
When the absolute number of HBV cases in the US is examined by state, there are five states that account for over 50% of the total HBV infections:
1. California, 347,100
2. New York, 169,400
3. Texas, 135,600
4. Florida, 108,500 and
5. New Jersey, 70,700

Read the full Journal of Viral Hepatitis article here: https://onlinelibrary.wiley.com/doi/10.1111/jvh.70122?fbclid=IwY2xjawPFLJJleHRuA2FlbQIxMQBicmlkETFIWEh0MXA4b3RJSlBnZzBKc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHjPWkVE5LQ_BgdOxoFud1qDphsRa4Slpyahh0zQ0uRdIOnU-w5bYxPM_680f_aem_gxRZiRcLzfslkJUr-4vGfA

Wishing you peace, health, and happiness this holiday season. We're looking forward to reengaging in 2026 to   in San Di...
12/19/2025

Wishing you peace, health, and happiness this holiday season. We're looking forward to reengaging in 2026 to in San Diego.

Outcomes of a tribal community program on hepatitis C, HIV, and syphilis screening, confirmation testing, and treatment ...
12/18/2025

Outcomes of a tribal community program on hepatitis C, HIV, and syphilis screening, confirmation testing, and treatment initiation for an underserved population.

BackgroundAmerican Indian and Alaska Native people are disproportionately impacted by hepatitis C, HIV, and syphilis, with rates 2.3, 1.9, and 6.4 times that...

California's Medi-Cals scored an A*, an advocacy report card for Hep C treatment.  There is one area were more advocacy ...
12/17/2025

California's Medi-Cals scored an A*, an advocacy report card for Hep C treatment. There is one area were more advocacy is needed.
💡Yes California imposes retreatment restrictions.
✅No prior authorization restriction.
✅No fibrosis restrictions.
✅No substance use restrictions.

Read report at https://stateofhepc.org/states/california/

National Viral Hepatitis Roundtable (NVHR), Harvard Law School Center for Health Law and Policy Innovation, Liver Coalition of San Diego

Together we can End the Epidemics ( ,   and  ). Here are two partner resources.✅HIV is preventable and treatable! More a...
12/11/2025

Together we can End the Epidemics ( , and ). Here are two partner resources.

✅HIV is preventable and treatable!
More about injectable PrEP from Planned Parenthood of the Pacific Southwest: www.planned.org/LGBTQ+

✅Hepatitis C is preventable, treatable, and curable!
More about sexual transmission from End Hep C SF: https://endhepcsf.org/sex-c-brochure/

Share these resources and help spread awareness!

A great resource.
12/11/2025

A great resource.

New online resource — Global Liver Institute Sharecare: Hepatitis C Patient Resource Center.Whether you’re newly diagnos...
12/04/2025

New online resource — Global Liver Institute Sharecare: Hepatitis C Patient Resource Center.

Whether you’re newly diagnosed or supporting someone living with hepatitis C, the Global Liver Institute and Sharecare have created a resource center to help. From emotional support tips to treatment guides, you’ll find practical advice, expert-backed facts, and culturally competent care tools all in one place.

https://www.sharecare.com/infections/hepatitis-c/emotionally-support-someone-hep-c?cbr=GLBL0002

Liver Coalition of San Diego is a member of Global Liver Institute's Liver Action Network.

If a loved one has hepatitis C, they'll probably need your emotional support. See how to comfort them with these practical tips.

Address

5755 Oberlin Drive, Suite 301
San Diego, CA
92121

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+18588000116

Alerts

Be the first to know and let us send you an email when End Hep C SD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to End Hep C SD:

Featured

Share